# Etanercept Treatment in the Early Course of Polymyalgia Rheumatica

> **NCT00524381** · PHASE3 · COMPLETED · sponsor: **Bispebjerg Hospital** · enrollment: 40 (estimated)

## Conditions studied

- Polymyalgia Rheumatica

## Interventions

- **DRUG:** Etanercept (Enbrel)
- **DRUG:** Sodium chloride (placebo)

## Key facts

- **NCT ID:** NCT00524381
- **Lead sponsor:** Bispebjerg Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-08
- **Primary completion:** 2009-07
- **Final completion:** 2009-09
- **Target enrollment:** 40 (ESTIMATED)
- **Last updated:** 2010-02-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00524381

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00524381, "Etanercept Treatment in the Early Course of Polymyalgia Rheumatica". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT00524381. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*